X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
humans (6) 6
cancer (5) 5
gene expression (4) 4
neuroblastoma (4) 4
animals (3) 3
genomes (3) 3
neuroblastoma - genetics (3) 3
proteins (3) 3
research (3) 3
tumors (3) 3
adp-ribosyl cyclase 1 - immunology (2) 2
article (2) 2
bioinformatics (2) 2
cell cycle (2) 2
cell differentiation (2) 2
cell differentiation - genetics (2) 2
cell line, tumor (2) 2
daratumumab (2) 2
development and progression (2) 2
dexamethasone (2) 2
enhancers (2) 2
epigenetics (2) 2
expression (2) 2
gene expression regulation, neoplastic (2) 2
genes (2) 2
genetic aspects (2) 2
genetics & heredity (2) 2
immunotherapy (2) 2
lenalidomide (2) 2
mesenchyme (2) 2
multidisciplinary sciences (2) 2
multiple myeloma (2) 2
multiple myeloma - immunology (2) 2
n-myc (2) 2
n-myc proto-oncogene protein (2) 2
neuroblastoma - pathology (2) 2
nuclear proteins - genetics (2) 2
nuclear proteins - metabolism (2) 2
oncogene proteins - genetics (2) 2
oncogene proteins - metabolism (2) 2
pediatrics (2) 2
physiological aspects (2) 2
risk stratification (2) 2
stem cells (2) 2
transcription factors (2) 2
ac133 antigen - genetics (1) 1
activation (1) 1
adenocarcinoma - blood supply (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - physiopathology (1) 1
adp-ribosyl cyclase 1 - genetics (1) 1
adrenergic neurons - cytology (1) 1
aged (1) 1
angiogenesis (1) 1
animal structures (1) 1
antibodies (1) 1
antibodies - immunology (1) 1
antibodies - metabolism (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens, neoplasm - immunology (1) 1
antitumor-activity (1) 1
b-cells (1) 1
b-lymphocytes - immunology (1) 1
binding proteins (1) 1
biological sciences (1) 1
blood vessels - physiopathology (1) 1
blotting, western (1) 1
care and treatment (1) 1
cd38 (1) 1
cd38 antibodies (1) 1
cd38 antigen (1) 1
cd38 expression (1) 1
cd49d antigen (1) 1
cd56 antigen (1) 1
cell biology (1) 1
cell identity (1) 1
cell lineage (1) 1
cell lines (1) 1
cell rna-seq (1) 1
cell-cycle (1) 1
cell-death (1) 1
cell-proliferation (1) 1
circuits (1) 1
classification (1) 1
clinical trials (1) 1
cluster analysis (1) 1
colon cancer (1) 1
colonic neoplasms - blood supply (1) 1
colonic neoplasms - pathology (1) 1
colonic neoplasms - physiopathology (1) 1
conditional expression (1) 1
consortia (1) 1
copy number defects (1) 1
correlation analysis (1) 1
daratumumab monotherapy (1) 1
developmental stages (1) 1
dexamethasone - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2012, Volume 109, Issue 47, pp. 19190 - 19195
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2017, Volume 23, Issue 24, pp. 7498 - 7511
Purpose: Daratumumab treatment results in a marked reduction of CD38 expression on multiple myeloma cells. The aim of this study was to investigate the... 
B-CELLS | TROGOCYTOSIS | DEXAMETHASONE | PHAGOCYTOSIS | MONOTHERAPY | NK CELLS | REGULATORY CELLS | ONCOLOGY | LENALIDOMIDE | RESISTANCE | MULTIPLE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Multiple Myeloma - immunology | Monocytes - immunology | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Granulocytes - drug effects | ADP-ribosyl Cyclase 1 - immunology | Killer Cells, Natural - immunology | Female | Gene Expression Regulation, Neoplastic - drug effects | Thalidomide - adverse effects | Dexamethasone - administration & dosage | ADP-ribosyl Cyclase 1 - genetics | Lenalidomide | T-Lymphocytes | Gene Expression Regulation, Neoplastic - immunology | Thalidomide - administration & dosage | Monocytes - drug effects | B-Lymphocytes - immunology | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Aged | Granulocytes - immunology | Multiple Myeloma - genetics | Plasma | Multiple myeloma | Clinical trials | Effector cells | Lymphocytes T | Proteins | Infusion | Reduction | Killer cells | Granulocytes | Lymphocytes | CD38 antigen | Natural killer cells | CD56 antigen | Immune system | Dexamethasone | CD49d antigen | Patients | Membrane proteins | Monocytes | Lymphocytes B | Experimental design | Plasma membranes | Leukocytes (granulocytic) | Cancer | CD38 | multiple myeloma | antibodies | daratumumab | immunotherapy
Journal Article
Nature genetics, ISSN 1061-4036, 2012, Volume 44, Issue 11, pp. 1199 - 1206
Journal Article
Nature genetics, ISSN 1061-4036, 2017, Volume 49, Issue 8, pp. 1261 - 1266
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 04/2019, Volume 10, Issue 1, pp. 1530 - 11
Transition between differentiation states in development occurs swift but the mechanisms leading to epigenetic and transcriptional reprogramming are poorly... 
STEM-CELLS | SIGNALING PATHWAYS | ACTIVATION | INTRATUMORAL HETEROGENEITY | SUPER-ENHANCERS | RNA-SEQ | MULTIDISCIPLINARY SCIENCES | CELL IDENTITY | TRANSCRIPTION | EXPRESSION | MASTERMIND | Transcription factors | Enhancers | Phenotypes | Mesenchyme | Circuits | Epigenetics | Genomes | Neuroblastoma | Feeds | Feedforward | Cancer
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e122 - e123
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2012, Volume 109, Issue 47, p. 19190
  Neuroblastoma is a pediatric tumor of the sympathetic nervous system. MYCN (V-myc myelocytomatosis viral-related oncogene, neuroblastoma derived [avian]) is... 
Proteins | Correlation analysis | Cell cycle | Nervous system | Gene expression | Tumors
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 03/2018, Volume 14, Issue 3, pp. 197 - 206
Introduction: Multiple myeloma (MM) is generally an incurable hematological malignancy with heterogeneous overall survival rates ranging from a few months to... 
isatuximab | MOR202 | smoldering myeloma | multiple myeloma | CD38 antibodies | immunotherapy | daratumumab | TAK-079 | DEXAMETHASONE | RISK STRATIFICATION | OPEN-LABEL | IMMUNOLOGY | ANTITUMOR-ACTIVITY | CELL-DEATH | TARGETING CD38 | THERAPY | LENALIDOMIDE | DARATUMUMAB MONOTHERAPY | CD38 EXPRESSION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.